Answers are grounded in this paper and cite their sources.
Swiss surveillance data confirm that resistance among uropathogenic E. coli isolates to nitrofurantoin and fosfomycin remains low. While resistance to 3rd/4th-generation cephalosporins also remains relatively low, it has been increasing and needs further surveillance. As for K. pneumoniae and P. mirabilis, high levels of susceptibility to 3rd-generation cephalosporins and quinolones were confirmed, while high prevalences of resistance to nitrofurantoin and fosfomycin discourage their use as first-line therapies for these pathogens. .
No takes yet. Share an insight, caveat, or question.
Zanichelli et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: